Journal for ImmunoTherapy of Cancer (Nov 2023)
603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study
Abstract
No abstracts available.